The manufacturing of APIs and bulk active substances involves multiple chemical and physical unit operations that demand stringent control of environment, cross‐contamination risk, and operator exposure. Key process steps and associated equipment include:
Throughout all these stages, the challenges include controlling dust, ensuring containment for high potency or toxic substances, preventing cross-contamination, and enabling efficient cleaning and maintenance.
In modern API manufacturing, isolators rated at OEB-4 / OEB-5 (or better) are increasingly common to protect operators and the environment from exposure to trace quantities of potent compounds. Additionally, barrier isolator designs deliver a higher level of separation compared to conventional RABS systems.
When handling APIs, especially potent compounds, you must manage:
Containment isolators provide the physical barrier, controlled airflow, HEPA/ULPA filtration, interlocked transfer ports, and validated leak testing needed to achieve those objectives.
Schematic has an extensive portfolio of isolators and containment systems tailored to bulk/drug manufacturing. Examples of offered solution types include:
These modular isolators can be configured around your existing equipment or built as integrated units. Options typically include safe-change HEPA/ULPA filters, interlocked transfer ports (RTP, alpha/beta valves), CIP/WIP capability, automated pressure testing, and flexible glove port layouts.
Key design features across Schematic’s isolator systems for API / bulk drug operations may include: